IOX THERAPEUTICS LTD.
iOx Therapeutics Ltd. operates as an immuno-oncology company. Founded in February 2015 by Professor Cerundolo, iOx Therapeutics is a spin-out from the University of Oxford started to commercialize discoveries made as part of a long-running collaboration between Oxford and the Ludwig Institute for Cancer Research. iOx intends to develop and commercialize multiple synthetic lipid compounds discovered by a research team led by Professor Cerundolo.
IOX THERAPEUTICS LTD.
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
950 K USD
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Employees Featured
Founder
Investors List
Portage Biotech
Portage Biotech investment in Convertible Note - iOx Therapeutics Ltd.
Horizon 2020
Horizon 2020 investment in Grant - iOx Therapeutics Ltd.